Corteva, Inc.


SKU: CTVA Category:


This is our first report on Corteva, a major agricultural player within the seeds and crop protection domain. The depth and breadth of the portfolio of the company is quite impressive. Moreover, its supply chain remained open since the beginning of 2022 despite the ongoing disruptions. The continuing growth in earnings and revenue demonstrates the strong foundation of the company. The company registered its Enlist Duo and Enlist One herbicides through 2029 with the U.S. EPA. Among major updates, Corteva Agriscience along with Marrone Bio, recently announced a new distribution contract whereby growers in Europe can now have access to a sustainable, novel option to enhance crop quality and plant health. The cost of some of the key co-formulates and raw materials has increased, which has driven the overall cost inflation impact on the company’s financials. Another big positive for the company is the increasing sales of innovative crop protection products. We initiate coverage on Corteva with a ‘Hold’ rating.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!